Lili Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lili Guo has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wu
Department of Neurosurgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
2 shared publications - Mengjun Zhang
Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, School of Medicine University of Electronic Science and Technology of China, Chengdu, China
2 shared publications - Xiaohong Qin
Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, School of Medicine University of Electronic Science and Technology of China, Chengdu, China
2 shared publications - Yunsen He
Department of Neurosurgery, Sichuan Lansheng Brain Hospital & Shanghai Lansheng Brain Hospital Investment Co., Ltd, Chengdu, China
2 shared publications - Bo Zhou
Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
1 shared publication - Caiquan Huang
Department of Neurosurgery, Wenjiang Hospital of Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication
Latest Publications
- 26 November 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (12) , 786
Differentiation between anti-CASPR2 encephalitis with initial psychiatric symptoms and primary psychiatric disorders, and a diagnostic prediction model: a prospective descriptive study
Background Anti-contactin-associated protein-like 2 (anti-CASPR2) encephalitis is highly susceptible to misdiagnosis as a primary psychiatric disorder when isolated psychiatric symptoms occur in its early stage. Methods Data on patients with acute or subacute psychiatric symptoms from January 2023 to March 2024 were collected and divided into an anti-CASPR2 encephalitis group (case group) and a primary psychiatric disorder group (control group). The differences between the two groups were evaluated, and logistic regression analysis was conducted to identify significant predictors of anti-CASPR2 encephalitis. Receiver operating characteristic (ROC) curve and decision curve analysis were used to evaluate the predictive performance and clinical utility of the anti-CASPR2 encephalitis model. Results The study included 18 patients with anti-CASPR2 encephalitis and 14 with primary psychiatric disorders. Patients in the case group were older on average and had a shorter onset time compared to the control group (P < 0.05). The case group reported fewer social life events and had a higher prevalence of positive cranial magnetic resonance imaging (MRI) findings and serum CASPR2 antibodies (P < 0.05). Binary logistic regression identified older age, shorter onset time and abnormal cranial MRI findings as independent risk factors for anti-CASPR2 encephalitis. The predictive model demonstrated high concordance with clinical observations and strong clinical utility. Conclusion Anti-CASPR2 encephalitis is more likely to occur in elderly patients with an acute onset, fewer social stressors, and abnormal cranial MRI findings. This diagnostic prediction model provides a reliable tool for the early differentiation between anti-CASPR2 encephalitis and primary psychiatric disorders.
- 26 November 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (12) , 786
Differentiation between anti-CASPR2 encephalitis with initial psychiatric symptoms and primary psychiatric disorders, and a diagnostic prediction model: a prospective descriptive study
Background Anti-contactin-associated protein-like 2 (anti-CASPR2) encephalitis is highly susceptible to misdiagnosis as a primary psychiatric disorder when isolated psychiatric symptoms occur in its early stage. Methods Data on patients with acute or subacute psychiatric symptoms from January 2023 to March 2024 were collected and divided into an anti-CASPR2 encephalitis group (case group) and a primary psychiatric disorder group (control group). The differences between the two groups were evaluated, and logistic regression analysis was conducted to identify significant predictors of anti-CASPR2 encephalitis. Receiver operating characteristic (ROC) curve and decision curve analysis were used to evaluate the predictive performance and clinical utility of the anti-CASPR2 encephalitis model. Results The study included 18 patients with anti-CASPR2 encephalitis and 14 with primary psychiatric disorders. Patients in the case group were older on average and had a shorter onset time compared to the control group (P < 0.05). The case group reported fewer social life events and had a higher prevalence of positive cranial magnetic resonance imaging (MRI) findings and serum CASPR2 antibodies (P < 0.05). Binary logistic regression identified older age, shorter onset time and abnormal cranial MRI findings as independent risk factors for anti-CASPR2 encephalitis. The predictive model demonstrated high concordance with clinical observations and strong clinical utility. Conclusion Anti-CASPR2 encephalitis is more likely to occur in elderly patients with an acute onset, fewer social stressors, and abnormal cranial MRI findings. This diagnostic prediction model provides a reliable tool for the early differentiation between anti-CASPR2 encephalitis and primary psychiatric disorders.
- 29 November 2023
- Published by Springer Nature in Neurosurgical Review
- Vol. 46 (1) , 1-40
Research process, recap, and prediction of Chiari malformation based on bicentennial history of nomenclature and terms misuse
There is an absent systematic analysis or review that has been conducted to clarify the topic of nomenclature history and terms misuse about Chiari malformations (CMs). We reviewed all reports on terms coined for CMs for rational use and provided their etymology and future development. All literature on the nomenclature of CMs was retrieved and extracted into core terms. Subsequently, keyword analysis, preceding and predicting (2023–2025) compound annual growth rate (CAGR) of each core term, was calculated using a mathematical formula and autoregressive integrated moving average model in Python. Totally 64,527 CM term usage was identified. Of these, 57 original terms were collected and then extracted into 24 core-terms. Seventeen terms have their own featured author keywords, while seven terms are homologous. The preceding CAGR of 24 terms showed significant growth in use for 18 terms, while 13, three, three, and five terms may show sustained growth, remain stable, decline, and rare in usage, respectively, in the future. Previously, owing to intricate nomenclature, Chiari terms were frequently misused, and numerous seemingly novel but worthless even improper terms have emerged. For a very basic neuropathological phenomenon tonsillar herniation by multiple etiology, a mechanism-based nosology seems to be more conducive to future communication than an umbrella eponym. However, a good nomenclature also should encapsulate all characteristics of this condition, but this is lacking in current CM research, as the pathophysiological mechanisms are not elucidated for the majority of CMs.
- 29 November 2023
- Published by Springer Nature in Neurosurgical Review
- Vol. 46 (1) , 1-40
Research process, recap, and prediction of Chiari malformation based on bicentennial history of nomenclature and terms misuse
There is an absent systematic analysis or review that has been conducted to clarify the topic of nomenclature history and terms misuse about Chiari malformations (CMs). We reviewed all reports on terms coined for CMs for rational use and provided their etymology and future development. All literature on the nomenclature of CMs was retrieved and extracted into core terms. Subsequently, keyword analysis, preceding and predicting (2023–2025) compound annual growth rate (CAGR) of each core term, was calculated using a mathematical formula and autoregressive integrated moving average model in Python. Totally 64,527 CM term usage was identified. Of these, 57 original terms were collected and then extracted into 24 core-terms. Seventeen terms have their own featured author keywords, while seven terms are homologous. The preceding CAGR of 24 terms showed significant growth in use for 18 terms, while 13, three, three, and five terms may show sustained growth, remain stable, decline, and rare in usage, respectively, in the future. Previously, owing to intricate nomenclature, Chiari terms were frequently misused, and numerous seemingly novel but worthless even improper terms have emerged. For a very basic neuropathological phenomenon tonsillar herniation by multiple etiology, a mechanism-based nosology seems to be more conducive to future communication than an umbrella eponym. However, a good nomenclature also should encapsulate all characteristics of this condition, but this is lacking in current CM research, as the pathophysiological mechanisms are not elucidated for the majority of CMs.
- Open Access
- 18 August 2023
- Published by Springer Nature in Research Square
Linc-NSC affects cell differentiation, apoptosis and proliferation in mouse neural stem cells and embryonic stem cells in vitro and in vivo
Background Stem cell therapy is a promising therapeutic strategy. Our previous study evaluated tumorigenicity by stereotactic transplantation of mouse neural stem cells (NSCs) and mouse embryonic stem cells (ESCs). When the mice were examined 28 days later, there was no evidence of tumor formation or long-term engraftment in the NSCs transplantation group. In contrast, due to the high proliferative capacity, ESCs transplantation caused tumor formation. Based on transcriptome sequencing, we found that a long intergenic noncoding RNA (named linc-NSC) with unknown structure and function was 1100 times more expressed on NSCs than on ESCs. It is suggested that linc-NSC is negatively correlated with stem cell pluripotency and tumor development, but positively correlated with neurogenesis. Therefore, we further wanted to clarify the role of linc-NSC in NSCs/ESCs in tumor formation and neurogenesis. Methods Whole transcriptome profiling by RNA sequencing and bioinformatics was used to predict the lncRNA widely associated with enhanced tumorigenicity. The expression of linc-NSC was assessed by quantitative real-time PCR. The cell proliferation assay, differentiation assay, immunofluorescence, flow cytometry in vitro, and survival rate and immunofluorescence assays in vivo were performed to investigate the impacts of linc-NSC on tumor formation and neurogenesis in NSCs and ESCs. Results We discovered that after the knockdown of linc-NSC in NSCs, NSCs cultured in vitro and those transplanted into the mouse cortex showed stronger survival ability, enhanced proliferation, and reduced apoptosis, and the opposite result was observed with linc-NSC overexpression in ESCs. Meanwhile, overexpression of linc-NSC in ECSs can induce enhanced apoptosis and differentiation, and inhibit tumorigenesis in vivo, reduction in tumor weight. Conclusions The linc-NSC, a promising gene-edited target, may promote the differentiation of mouse NSCs and inhibit tumorigenesis of mouse ESCs. In other words, knockdown of linc-NSC inhibits NSCs apoptosis in vitro and in vivo, and is unable to trigger tumor formation, revealing a new dimension into the lncRNA of low survival NSCs and providing a prospective gene manipulation target before transplantation. In parallel, overexpression of linc-NSC induces ESCs apoptosis in vitro and in vivo,attenuating the tumorigenicity of ESCs in vivo, although it can’t completely prevent tumor formation.
- 18 August 2023
- Published by Springer Nature in Research Square
Open AccessLinc-NSC affects cell differentiation, apoptosis and proliferation in mouse neural stem cells and embryonic stem cells in vitro and in vivo
Background Stem cell therapy is a promising therapeutic strategy. Our previous study evaluated tumorigenicity by stereotactic transplantation of mouse neural stem cells (NSCs) and mouse embryonic stem cells (ESCs). When the mice were examined 28 days later, there was no evidence of tumor formation or long-term engraftment in the NSCs transplantation group. In contrast, due to the high proliferative capacity, ESCs transplantation caused tumor formation. Based on transcriptome sequencing, we found that a long intergenic noncoding RNA (named linc-NSC) with unknown structure and function was 1100 times more expressed on NSCs than on ESCs. It is suggested that linc-NSC is negatively correlated with stem cell pluripotency and tumor development, but positively correlated with neurogenesis. Therefore, we further wanted to clarify the role of linc-NSC in NSCs/ESCs in tumor formation and neurogenesis. Methods Whole transcriptome profiling by RNA sequencing and bioinformatics was used to predict the lncRNA widely associated with enhanced tumorigenicity. The expression of linc-NSC was assessed by quantitative real-time PCR. The cell proliferation assay, differentiation assay, immunofluorescence, flow cytometry in vitro, and survival rate and immunofluorescence assays in vivo were performed to investigate the impacts of linc-NSC on tumor formation and neurogenesis in NSCs and ESCs. Results We discovered that after the knockdown of linc-NSC in NSCs, NSCs cultured in vitro and those transplanted into the mouse cortex showed stronger survival ability, enhanced proliferation, and reduced apoptosis, and the opposite result was observed with linc-NSC overexpression in ESCs. Meanwhile, overexpression of linc-NSC in ECSs can induce enhanced apoptosis and differentiation, and inhibit tumorigenesis in vivo, reduction in tumor weight. Conclusions The linc-NSC, a promising gene-edited target, may promote the differentiation of mouse NSCs and inhibit tumorigenesis of mouse ESCs. In other words, knockdown of linc-NSC inhibits NSCs apoptosis in vitro and in vivo, and is unable to trigger tumor formation, revealing a new dimension into the lncRNA of low survival NSCs and providing a prospective gene manipulation target before transplantation. In parallel, overexpression of linc-NSC induces ESCs apoptosis in vitro and in vivo,attenuating the tumorigenicity of ESCs in vivo, although it can’t completely prevent tumor formation.